Abstract: In order to increase performances of an iron oxide-potassium oxide system catalyst to be used for an alkyl aromatic hydrocarbon dehydrogenation reaction in the presence of steam, there is provided an alkyl aromatic hydrocarbon dehydrogenation catalyst wherein a little amount of titanium oxide is added by the mixing and kneading method or by the preceding addition to iron oxide in the production of the iron oxide-potassium oxide system catalyst to be used for the alkyl aromatic hydrocarbon dehydrogenation reaction in the presence of steam. The iron oxide-potassium oxide system catalyst is allowed to contain a little amount of titanium oxide, whereby an activity can be remarkably increased, as well as a selectivity in the same conversion ratio can also be improved in the alkyl aromatic hydrocarbon dehydrogenation reaction, and further the obtained catalyst exhibits stable performances with time on stream.

Abstract: The present invention provides a power flame retardant for a halogen-containing vinyl resin, which comprises the following Components A, B and C. (A) 5 to 30 parts by weight of at least one of alkali metal compound of lithium, sodium and potassium calculated as the formula M.sub.2 O where M is an alkali metal; (B) 0.2 to 10 parts by weight of a perchloric acid radical in the form of the acid or a salt or amine thereof, calculated as perchloric acid radical; and (C) 1 to 50 parts by weight of a hydrophobic dispersing agent having a boiling point or a decomposition temperature of 200.degree. C. or higher. All the parts by weight are based on 100 parts by weight of antimony pentoxide (Sb.sub.2 O.sub.5). The flame retardant of the present invention does not impair transparency of the halogen-containing vinyl resin, and also does not worsen various physical properties such as thermal stability and weathering resistance.

Abstract: There is disclosed a process for preparing colloidal sols of antimony pentoxide in organic solvents which comprises the steps of:(a) reacting an alkali antimonate with 0.5 to 5 times of a monovalent or divalent inorganic acid in terms of stoichiometric ratio to form an antimony pentoxide gel,(b) after separating and washing the gel, aging the resulting wet cake at room temperature to 100.degree. C., and(c) peptizing the product in an organic solvent with Sb.sub.2 O.sub.5 being added, in terms of % by weight, 2 to 30% of an organic base and 0.2 to 20% of an organic acid as peptizing auxiliaries, and then removing water contained therein.

Abstract: There is disclosed a process for preparing stable colloidal sols of antimony pentoxide in organic solvents which comprises the steps of adjusting an amount of an organic base in an aqueous colloidal solution of antimony pentoxide to, in terms of % by weight, 2 to 30% based on antimony pentoxide in the aqueous colloidal solution of antimony pentoxide; adding an organic acid in an amount of 0.2 to 20%; and replacing a dispersing medium of the colloidal solution from water to an organic solvent.

Abstract: Disclosed is a positively charged antimony pentoxide sol, comprising colloidal particles of antimony pentoxide sol coated on their surfaces with at least one of trivalent and tetravalent metals, the content of the metals being 1 to 50% by weight in terms of the metal oxide based on antimony pentoxide in the antimony pentoxide sol.When the positively charged antimony pentoxide sol of this invention is mixed with a cationic resin emulsion or an aqueous solution of a cationic water-soluble polymer, no agglomeration occurs and also, when it is added into an aqueous solution of an inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, etc., or an organic acid such as acetic acid, propionic acid, oxalic acid, maleic acid, etc.

Abstract: Phosphorus-containing oligopeptide derivatives are prepared by synthetic methods. The compounds exhibit angiotensin converting enzyme-inhibiting action and are, therefore, useful as anti-hypertensive agents.

Abstract: A quinoline-N-oxide derivative represented by the formula: ##STR1## wherein X is hydroxy, lower alkoxy, lower alkylthio, unsubstituted or substituted aralkyloxy, or unsubstituted or substituted aralkylthio; Y is a hydrogen atom or halogen atom; R.sub.1 is alkylene or alkenylene having 3 to 15 carbon atom; Z is hydroxymethyl, lower alkoxymethyl, unsubstituted or substituted aryloxymethyl, tetrahydropyranyloxymethyl, tetrahydrofuranyloxymethyl, unsubstituted or substituted arylsulfonyloxymethyl, lower alkylthiomethyl, unsubstituted or substituted arylthiomethyl, lower alkylsulfinylmethyl, unsubstituted or substituted arylsulfinylmethyl, lower alkylsulfonylmethyl, unsubstituted or substituted arylsulfonylmethyl, aminomethyl, --CH.sub.2 NHR.sub.2 (wherein R.sub.2 is lower alkyl, unsubstituted or substituted aralkyl, or unsubstituted or substituted aryl), --CH.sub.2 NR.sub.3 R.sub.4 (wherein R.sub.3 and R.sub.4 are lower alkyl, unsubstituted or substituted aralkyl, or unsubstituted or substituted aryl), --CH.sub.

Abstract: A process for preparing an antimony pentoxide sol, which comprises dispersing sodium antimonate in water, reacting the sodium antimonate with a monovalent or divalent inorganic acid added in a stoichiometrical amount of 0.7 time to 5 times the amount of the sodium antimonate to form the sodium salt of said inorganic acid and an antimony pentoxide gel, separating and water washing said gel, dispersing said gel in water, and peptizing said gel dispersed in water by adding an organic base in an amount to provide a stoichiometrical amount of base / Sb.sub.2 O.sub.5 of from 0.03 to 1.

Abstract: Offered is an anticonvulsive composition which comprises an effective amount of a dihydrouracil derivative represented by the formula: ##STR1## [wherein one of A and B is ##STR2## (wherein Y.sub.1, Y.sub.2 and Y.sub.3 are hydrogen atoms, lower alkyl groups, halogen atoms, nitro groups, amino groups, carboxyl groups, lower alkoxycarbonyl groups or trifluoromethyl groups), a naphthyl group or a diphenylmethyl group, and the other is a hydrogen atom, a lower alkyl group, a lower alkenyl group, a cyclopentyl group, a cyclohexyl group or ##STR3## (wherein Z.sub.1, Z.sub.2 and Z.sub.3 are hydrogen atoms, lower alkyl groups, halogen atoms or trifluoromethyl groups), R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms or lower alkyl groups, and X is an oxygen atom or a sulfur atom] and at least one pharmaceutically acceptable carrier.

Abstract: A new piperidine derivative represented by the formula: ##STR1## wherein X is oxygen, sulfur, carbonyl, hydroxymethylene or methylene; R.sub.1 is straight-chain alkylene having 1-4 carbon atoms with or without lower alkyl substituent(s); (A).sub.m and R.sub.2 are usually used substituents; and Y is a monovalent group or a divalent group and is one of the following three groups: ##STR2## wherein when p is 0, B is --N.dbd.N--, ##STR3## and when p is 1, B is ##STR4## wherein (R.sub.3).sub.n is a usually used substituent, has hypotensive activity.

Abstract: New piperidine derivatives which have a useful pharmacological activity such as hypotensive activity are prepared.

Abstract: New piperidine derivatives which have a useful pharmacological activity such as hypotensive activity are prepared.

Abstract: A new piperidine derivative represented by the formula: ##STR1## wherein X is oxygen, sulfur, carbonyl, hydroxymethylene or methylene; R is straight-chain alkylene having 1-4 carbon atoms with or without lower alkyl substituent(s); m and n are 0 or 1, and are different from each other (i.e., both m and n are not 0 or 1); and (D).sub.m', R.sup.1 and (R.sup.2)n' are usually used as substituents, has a hypotensive activity.

Abstract: Novel compounds are disclosed which are useful as agents capable, when applied to citrus tree, of modifying the metabolism and organic acid content of the citrus fruit.

Abstract: This invention relates to certain derivatives of phenylalanine having interesting pharmaceutical properties, in particular, a lipid-lowering activity.

Abstract: Amino acid-urethane copolymers improved in elongation, tensile strength and flexing endurance are prepared by polymerizing a prepolymer having terminal isocyanate groups, obtained by reacting a polyether polyol having hydroxyl groups substantially at the terminals thereof with an organic polyisocyanate in a ratio in equivalent of the organic polyisocyanate to the polyether polyol of 1.6 to 2.5, either with an amino acid-N-carboxylic acid anhydride or with a polyamino acid polymer obtained by polymerizing an amino acid-N-carboxylic acid anhydride.